Perrigo | PRGO - Debt



Perrigo reported $3.65B in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
AbbVie USD 69.89B 2.74B Mar/2025
Abbott USD 13.44B 195M Jun/2025
Bayer EUR 39.39B 1.31B Mar/2025
Bristol-Myers Squibb USD 50.93B 1.22B Jun/2025
Corcept Therapeutics USD 6.6M 6.6M Jun/2025
Dr.Reddys Laboratories INR 48.64B 1.88B Jun/2025
Eli Lilly USD 39.9B 1.39B Jun/2025
J&J USD 52.25B 15.62B Mar/2025
Merck USD 34.84B 2.27B Mar/2025
Nestle CHF 63.56B 2.31B Dec/2024
Pacira USD 580.49M 2.88M Jun/2025
Perrigo USD 3.65B 24.4M Jun/2025
Pfizer USD 60.93B 1.18B Jun/2025
Prestige Brands USD 1.04B 27.25M Jun/2025
Reckitt Benckiser GBP 8.66B 238M Dec/2024
Sanofi 22.28B 1.24B Jun/2025
Supernus Pharmaceuticals USD 31.77M 531K Jun/2025
Teva Pharmaceutical Industries USD 17.52B 872M Jun/2025
Xeris Pharmaceuticals USD 257.22M 10.01M Jun/2025
Zoetis USD 6.79B 214M Jun/2025